The Generics and Biosimilars Initiative (GaBI) aims to build a one-stop portal containing, e.g. a worldwide guideline repository and an archive containing related scientific information, seeking to provide readers with the latest updates on developments in relation to generic and biosimilar medicines, while at the same time serving as a communication vehicle to reach key members of the healthcare world.

GaBI Online subscribers stay informed by receiving weekly online news alerts, reports on drug development, related scientific events and more.

E-Commerce

Exponential Platform